Mead Johnson and American Home Products propose to pay $39 mil. and $8 mil., respectively, to settle a federal suit filed two years ago by 21 wholesalers and retailers accusing the companies of conspiring to fix prices on infant formula to wholesalers, the two companies announce July 2. The two firms do not admit guilt but say they chose to settle to avoid costly litigation. The proposal must still be approved by the wholesaler group. The suit also names Abbott, the U.S.'s largest infant formula maker, but a settlement has not yet been negotiated. Mead Johnson and AHP on June 11 reached an infant formula settlement agreement with the Federal Trade Commission ("The Pink Sheet" June 15, T&G-11). Mead Johnson will take a pre-tax charge of $46 mil. to cover the settlements.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth